The Festival of Biologics event, renowned for bringing together industry leaders and innovators, will take place from October 15-17, 2024. Nextera will be showcasing its latest research and PoC on targeting peptide HLA in oncology, utilizing our proprietary NextCore platform to discover unique TCR-like antibodies and demonstrates low picomolar efficacy when reformatted to T ell engagers (TCEs). This pioneering work will be presented in a poster ‘Development and Preclinical Evaluation of a TCR-like antibody T Cell Engager targeting MAGE-A4 in Cancer’ (ID151), highlighting our contribution to advancing cancer treatment through innovative biologics. Attendees are encouraged to visit our poster presentation and connect with our team to discuss potential collaborations and the future of biologics in oncology.
https://www.terrapinn.com/conference/festival-of-biologics/agenda.stm
